CYTOSORBENTS CORPORATION: 10-Q filed 2015-11-13

Name: CYTOSORBENTS CORPORATION: 10-Q filed 2015-11-13
Creator: CYTOSORBENTS CORPORATION

What CYTOSORBENTS CORPORATION reported in its quarterly report filed 2015-11-13 (fiscal Q3 2015): 29 published measures, 79 facts as tagged in accession 0001144204-15-064966.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-13
Fiscal period: fiscal Q3 2015
Accession: 0001144204-15-064966 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	12,802,300	USD
At 2014-12-31	8,468,625	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	9,355,454	USD
At 2014-12-31	3,963,183	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	7,385,591	USD
At 2014-12-31	3,605,280	USD
At 2014-09-30	433,423	USD
At 2013-12-31	2,183,030	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,847,441	USD	92
2015-01-01 to 2015-09-30	-6,130,065	USD	273
2014-07-01 to 2014-09-30	-1,498,350	USD	92
2014-01-01 to 2014-09-30	-4,327,035	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	296,362	USD	273
2014-01-01 to 2014-09-30	89,495	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-130,524,185	USD
At 2014-12-31	-124,394,120	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	479,537	USD
At 2014-12-31	245,821	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	260,232	USD	273
2014-01-01 to 2014-09-30	150,273	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,150,296	USD	92
2015-01-01 to 2015-09-30	-6,640,891	USD	273
2014-07-01 to 2014-09-30	-1,483,553	USD	92
2014-01-01 to 2014-09-30	-3,989,568	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	11,591,491	USD
At 2014-12-31	7,607,006	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	3,446,846	USD
At 2014-12-31	4,505,442	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	526,670	USD
At 2014-12-31	698,307	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	553,383	USD
At 2014-12-31	819,151	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	2,855,091	USD	92
2015-01-01 to 2015-09-30	8,262,771	USD	273
2014-07-01 to 2014-09-30	2,170,010	USD	92
2014-01-01 to 2014-09-30	5,434,164	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2015-09-30	1,337,185	USD
At 2014-12-31	537,566	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	704,795	USD	92
2015-01-01 to 2015-09-30	1,621,880	USD	273
2014-07-01 to 2014-09-30	686,457	USD	92
2014-01-01 to 2014-09-30	1,444,596	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	1,700,035	USD	92
2015-01-01 to 2015-09-30	4,841,600	USD	273
2014-07-01 to 2014-09-30	1,240,497	USD	92
2014-01-01 to 2014-09-30	3,518,374	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	866,334	USD	92
2015-01-01 to 2015-09-30	2,619,018	USD	273
2014-07-01 to 2014-09-30	880,292	USD	92
2014-01-01 to 2014-09-30	1,464,059	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	25,177,005	shares
At 2014-12-31	23,304,640	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-09-30	139,408,750	USD
At 2014-12-31	128,106,297	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-09-30	445,712	USD
At 2014-12-31	227,701	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	731,272	USD
At 2014-12-31	615,798	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2015-09-30	372,332	USD
At 2014-12-31	700,462	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,897,248	USD	92
2015-01-01 to 2015-09-30	-5,912,054	USD	273
2014-07-01 to 2014-09-30	-1,380,318	USD	92
2014-01-01 to 2014-09-30	-4,203,852	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-2,847,441	USD	92
2015-01-01 to 2015-09-30	-6,130,065	USD	273
2014-07-01 to 2014-09-30	-2,779,408	USD	92
2014-01-01 to 2014-09-30	-8,096,854	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-697,145	USD	92
2015-01-01 to 2015-09-30	510,826	USD	273
2014-07-01 to 2014-09-30	-14,797	USD	92
2014-01-01 to 2014-09-30	-337,467	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	9,408,584	USD	273
2015-01-13 to 2015-01-14	9,409,000	USD	2
2014-01-01 to 2014-09-30	9,751,455	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-237,202	USD	273
2014-01-01 to 2014-09-30	112,183	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	769,352	USD	273
2014-01-01 to 2014-09-30	141,467	USD	273

Inspect the source

Entity: CYTOSORBENTS CORPORATION / CIK 0001175151
Captured: 2026-09-20T07:44:44.168Z
SEC response SHA-256: 8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))